MedPath

Impact of a Resource-based Life Review Intervention on Advanced Cancer Patients

Not Applicable
Completed
Conditions
Advanced Cancer
Interventions
Behavioral: Revie ⊕
Registration Number
NCT04254926
Lead Sponsor
School of Health Sciences Geneva
Brief Summary

The main objective of the present study is to evaluate the effects of the Revie ⊕ intervention on the self-esteem of patients diagnosed with an advanced cancer. A pragmatic, two-arm parallel-group, waitlist randomized controlled trial is conducted. The study takes place in the oncology department of the University Hospitals of Geneva at 3 outpatient units.

Detailed Description

The main objective of the present study is to evaluate the effects of the Revie ⊕ intervention on the self-esteem of patients diagnosed with an advanced cancer. The secondary objectives are to evaluate the effects of the Revie ⊕ intervention on spiritual well-being, personal development, life satisfaction, and the perception of the interaction with the nurses. A pragmatic, two-arm parallel-group, waitlist randomized controlled trial (WLRCT) is conducted in which participants are randomized into (i) intervention, or (ii) waitlist control groups. The intervention group (IG) receives the Revie ⊕ intervention early on and the control group (CG) the same intervention but later on (i.e., after eight weeks).This monocentric study takes place in the oncology department of the University Hospitals of Geneva (HUG) at two outpatient units (planned n=102; 51 per group).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
71
Inclusion Criteria
  • Adults 18 years with and advanced cancer,
  • whose general health status is adequate for participation in the study based on a clinical assessment by the nurse / doctor; and
  • who consent to participate in the study.
Exclusion Criteria
  • documented cognitive impairment that compromises capacity for discernment,
  • command of French is insufficient for reading, writing, or conversing.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Revie ⊕ intervention earlyRevie ⊕participants randomized into (i) the intervention group (IG) receive the Revie ⊕ intervention early on.
Revie ⊕ intervention laterRevie ⊕The control group (CG) receives the same intervention Revie ⊕ but later on (i.e., after eight weeks).
Primary Outcome Measures
NameTimeMethod
Self-esteemBaseline, change from Baseline at 2 months, change from Baseline at 4 months

Self-esteem will be measured by the Rosenberg Self-Esteem Scale (RSE, 10 items) developed in 1965 (French version).

Minimum value = 1 Maximum value = 4. A score above 30 points corresponds to a high level of self-esteem, between 20 and 30 points indicates a moderate self-esteem, and a score of less than 20 points reflects a low self-esteem.

Secondary Outcome Measures
NameTimeMethod
Personal developmentBaseline, change from Baseline at 2 months, change from Baseline at 4 months

Personal development will be measured by the Post-Traumatic Growth Inventory (PTGI) instrument developed by Tedeschi and Calhoun in 1996 Minimum value = 1 Maximum value = 6. A high score means a high level of development.

Spiritual well-beingBaseline, change from Baseline at 2 months, change from Baseline at 4 months

Spiritual well-being will be measured by the Functional Assessment of Chronic Illness Therapy-spiritual well-being (FACIT-Sp).

Minimum value = 0 Maximum value = 4. The higher the score, the better the spiritual well-being.

Satisfaction with lifeBaseline, change from Baseline at 2 months, change from Baseline at 4 months

Satisfaction with life will be measured with the Satisfaction With Life Scale (SWLS) instrument developed by Pavot and Diener in 1985.

Minimum value = 1 Maximum value = 7. A high score means a high level of satisfaction with life.

The patient's perception of their interaction with the nurseBaseline, change from Baseline at 2 months, change from Baseline at 4 months

The Nurse-Patient-Interaction Scale (NPIS) questionnaire developed by Haugan in 2012 will be used to evaluate the patient's perception of their interaction with the nurse Minimum value = 1 Maximum value = 10. A high score means a great appreciation of interaction.

Trial Locations

Locations (2)

Hopitaux Universitaires de Genève

🇨🇭

Geneva, Switzerland

Haute école de santé

🇨🇭

Geneva, Switzerland

© Copyright 2025. All Rights Reserved by MedPath